Market Cap 1.82B
Revenue (ttm) 277.25M
Net Income (ttm) 27.31M
EPS (ttm) N/A
PE Ratio 53.38
Forward PE 24.77
Profit Margin 9.85%
Debt to Equity Ratio 0.08
Volume 3,434,300
Avg Vol 3,269,214
Day's Range N/A - N/A
Shares Out 117.43M
Stochastic %K 9%
Beta 0.89
Analysts Sell
Price Target $21.00

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 848 5100
Fax: 510 848 1327
Address:
2100 Powell Street, Suite 720, EmeryVille, United States
pauliedeee
pauliedeee Feb. 3 at 10:40 PM
$VXRT $DVAX $SNY Coming soon to a theater near you!
0 · Reply
TwongStocks
TwongStocks Feb. 3 at 9:10 PM
$DVAX Equity Corporate Actions Alert #2026 - 67 Information Regarding the Tender Offer of Dynavax Technologies Corporation (DVAX) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-67 The tender offer by Samba Merger Sub, Inc. to acquire all of the outstanding common stock of Dynavax Technologies Corporation (DVAX) is scheduled to expire one minute after 11:59 p.m. ET, on February 9, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on February 10, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on February 9, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (February 10) and will be suspended effective February 11, 2026. DVAX shareholders will receive $15.50 per share at closing.
0 · Reply
Dilly_Due
Dilly_Due Feb. 3 at 2:39 PM
$VXRT $DVAX $SNY $MRK Wouldn't be the first time.... Think $30+/share is unattainable? From chat GPT. Just my humble opinion. Do your own DD.
0 · Reply
Vax87
Vax87 Feb. 2 at 9:44 PM
$VXRT If it is true, that $SNY was in talks for at least 2 years with $DVAX , then, $SNY obviously prodded them to follow through with the Vaxart deal. If I told you 6 months ago that Sanofi was going to buy the rights to our Covid vaccine with the same terms that we got through the Dvax deal, what would the reaction have been? Well, everyone would have gone crazy if it truly happened, and, we would have all expected the share price to have gone 2+ instantly. Well, the reality is, it did happen. Why is the share price still meandering here? Does anyone think that the share price has yet to react to this reality, as unbelievable as that sounds?
2 · Reply
KWalzz
KWalzz Feb. 2 at 1:08 PM
$DVAX and another "unimportant" amendment to SC14D9. it is only about CEO Spencer listed 11 million while it was 6 million (compensation for GS). I mean who needs to be correct in financial matters or so? LOL
0 · Reply
KWalzz
KWalzz Jan. 30 at 3:51 PM
$DVAX and another 2 SEC filings, again 2 amendments related to regulatory things. nothing special here. TO on rails is the message.
0 · Reply
chrlaff01
chrlaff01 Jan. 30 at 1:28 PM
$DVAX You guys, I sold after the buyout was announced. I was desperate to relocate my capital. There may be a bidding war, but I didn’t want to take the risk of waiting. I’ll continue checking in here periodically. Good luck to you all.
3 · Reply
KWalzz
KWalzz Jan. 29 at 8:16 AM
$DVAX as I already wrote yesterday, HSR is cleared according to the SEC filing TO-T/A: "The waiting period under the HSR Act expired, effective January 27, 2026 at 11:59 p.m. Eastern Time" The German FCO (Federal Cartel Office) had already cleared by January, 5. Some not so important lawsuits by private investors, the usual noise. No other amendments so far, no pulic opinion or noise from Deep Track, no other offer noise so far, so it seems TO is on rails.
1 · Reply
Iaipres1A
Iaipres1A Jan. 28 at 7:45 PM
$DVAX Why is there so much volume at $15 if the deal is fate complete at the deal price is $15? What's the bet
1 · Reply
LUCKY_Cool_Cat
LUCKY_Cool_Cat Jan. 28 at 3:18 PM
$DVAX Retail is less than 2%, so sale isnt about them, never was. Just saying.
0 · Reply
Latest News on DVAX
Sanofi to acquire US biotech Dynavax for $2.2 billion

Dec 24, 2025, 3:08 AM EST - 5 weeks ago

Sanofi to acquire US biotech Dynavax for $2.2 billion

SNY


Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

Dec 24, 2025, 1:49 AM EST - 5 weeks ago

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

SNY


3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 4 months ago

3 Of My Favorite Biotech Stocks Under $10

FOLD MRNA NUVB PFE


Dynavax Technologies: A Dip To Accumulate

Aug 11, 2025, 8:41 AM EDT - 6 months ago

Dynavax Technologies: A Dip To Accumulate


Dynavax Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:00 PM EDT - 6 months ago

Dynavax Reports Second Quarter 2025 Financial Results


Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 4:59 PM EDT - 8 months ago

Dynavax Comments on Glass Lewis Recommendation


Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 6:12 PM EDT - 9 months ago

Deep Track Capital Comments on ISS Recommendation


Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 21, 2025, 11:48 PM EDT - 9 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good


Dynavax Files Preliminary Proxy Statement

Apr 3, 2025, 5:40 PM EDT - 10 months ago

Dynavax Files Preliminary Proxy Statement


pauliedeee
pauliedeee Feb. 3 at 10:40 PM
$VXRT $DVAX $SNY Coming soon to a theater near you!
0 · Reply
TwongStocks
TwongStocks Feb. 3 at 9:10 PM
$DVAX Equity Corporate Actions Alert #2026 - 67 Information Regarding the Tender Offer of Dynavax Technologies Corporation (DVAX) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-67 The tender offer by Samba Merger Sub, Inc. to acquire all of the outstanding common stock of Dynavax Technologies Corporation (DVAX) is scheduled to expire one minute after 11:59 p.m. ET, on February 9, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on February 10, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on February 9, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (February 10) and will be suspended effective February 11, 2026. DVAX shareholders will receive $15.50 per share at closing.
0 · Reply
Dilly_Due
Dilly_Due Feb. 3 at 2:39 PM
$VXRT $DVAX $SNY $MRK Wouldn't be the first time.... Think $30+/share is unattainable? From chat GPT. Just my humble opinion. Do your own DD.
0 · Reply
Vax87
Vax87 Feb. 2 at 9:44 PM
$VXRT If it is true, that $SNY was in talks for at least 2 years with $DVAX , then, $SNY obviously prodded them to follow through with the Vaxart deal. If I told you 6 months ago that Sanofi was going to buy the rights to our Covid vaccine with the same terms that we got through the Dvax deal, what would the reaction have been? Well, everyone would have gone crazy if it truly happened, and, we would have all expected the share price to have gone 2+ instantly. Well, the reality is, it did happen. Why is the share price still meandering here? Does anyone think that the share price has yet to react to this reality, as unbelievable as that sounds?
2 · Reply
KWalzz
KWalzz Feb. 2 at 1:08 PM
$DVAX and another "unimportant" amendment to SC14D9. it is only about CEO Spencer listed 11 million while it was 6 million (compensation for GS). I mean who needs to be correct in financial matters or so? LOL
0 · Reply
KWalzz
KWalzz Jan. 30 at 3:51 PM
$DVAX and another 2 SEC filings, again 2 amendments related to regulatory things. nothing special here. TO on rails is the message.
0 · Reply
chrlaff01
chrlaff01 Jan. 30 at 1:28 PM
$DVAX You guys, I sold after the buyout was announced. I was desperate to relocate my capital. There may be a bidding war, but I didn’t want to take the risk of waiting. I’ll continue checking in here periodically. Good luck to you all.
3 · Reply
KWalzz
KWalzz Jan. 29 at 8:16 AM
$DVAX as I already wrote yesterday, HSR is cleared according to the SEC filing TO-T/A: "The waiting period under the HSR Act expired, effective January 27, 2026 at 11:59 p.m. Eastern Time" The German FCO (Federal Cartel Office) had already cleared by January, 5. Some not so important lawsuits by private investors, the usual noise. No other amendments so far, no pulic opinion or noise from Deep Track, no other offer noise so far, so it seems TO is on rails.
1 · Reply
Iaipres1A
Iaipres1A Jan. 28 at 7:45 PM
$DVAX Why is there so much volume at $15 if the deal is fate complete at the deal price is $15? What's the bet
1 · Reply
LUCKY_Cool_Cat
LUCKY_Cool_Cat Jan. 28 at 3:18 PM
$DVAX Retail is less than 2%, so sale isnt about them, never was. Just saying.
0 · Reply
AccuRoger
AccuRoger Jan. 28 at 2:33 PM
$DVAX See the SEC document released this morning for this announcement: Regulatory Approvals — Compliance with the HSR Act” on page 63: “The waiting period under the HSR Act expired, effective January 27, 2026 at 11:59 p.m. Eastern Time. Accordingly, the condition to the Offer requiring that the waiting period (or any extension thereof) applicable to the Offer and the Merger under the HSR Act shall have expired or been terminated has been satisfied.” There is additional information about investor complaints. They will not stop the deal from closing IMHO.
0 · Reply
KWalzz
KWalzz Jan. 28 at 1:09 PM
$DVAX new SEC filings are out, TO-T/A and SC 14D9/A. 1. HSR act expired Jan/27 and is cleared, German FCO cleared Jan/14, so this is ou of the way. 2. Shareholder lawsuits are listed. These lawsuits allege: - Disclosure deficiencies - Negligence - Violations of tender‑offer rules (Sections 14(d) and 14(e)) And they seek: - To block the deal - Or obtain additional disclosures - Or obtain attorneys’ fees No indication that big insts tendered so far. Have no time to look more into it. Do your own dd and myod.
0 · Reply
KWalzz
KWalzz Jan. 27 at 8:50 AM
$DVAX my 2 cents: of course do your own dd & myod. I still hold, no need to tender. In worst case I get 15.50 per share. I joined class actions: absolutely no costs, no risks, in best case I receive money and in worst case nothing. So no damage done. Do not let you distract.
1 · Reply
KWalzz
KWalzz Jan. 27 at 8:43 AM
$DVAX 2/2:
0 · Reply
KWalzz
KWalzz Jan. 27 at 8:43 AM
$DVAX 1/2:
0 · Reply
triniblockchain
triniblockchain Jan. 26 at 4:53 PM
$DVAX how long yll plan to wait for another bid while other equities could be invested in ?
0 · Reply
KWalzz
KWalzz Jan. 26 at 8:38 AM
$DVAX 3/3:
0 · Reply
KWalzz
KWalzz Jan. 26 at 8:37 AM
$DVAX 2/3:
0 · Reply
KWalzz
KWalzz Jan. 26 at 8:37 AM
$DVAX 1/3:
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 24 at 5:08 PM
$DVAX RSI: 58.67, MACD: 0.8661 Vol: 0.13, MA20: 15.51, MA50: 12.82 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OhioTrader
OhioTrader Jan. 23 at 6:09 PM
$DVAX Did Mr Novak undersell the shareholders AND get to sell his shares for over asking price? A court may decide!
1 · Reply
KWalzz
KWalzz Jan. 23 at 5:38 PM
$DVAX Google says 😆 re lawsuit (including the old one)
1 · Reply